Get started
Author

Heidi L. Meyer

Observed names: H. L. Meyer, H. Meyer, Heidi Meyer, Meyer, Heidi
OpenAlex ID: A5013978050
Measles Virus Replication in Lungs of Hispid Cotton Rats after Intranasal Inoculation
1992 · P. R. Wyde, M. W. Ambrose, et al. · Experimental Biology and Medicine · 51
Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA – Results of an international collaborative study
2017 · Sylvie Morgeaux, Bertrand Poirier, et al. · Vaccine · 47
Evaluation of the toxicity and antiviral activity of carbocyclic 3-deazaadenosine against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats
1990 · Philip R. Wyde, Mark W. Ambrose, et al. · Antiviral Research · 40
Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats
1991 · Mark W. Ambrose, Philip R. Wyde, et al. · Vaccine · 35
Beschluss und Wissenschaftliche Begründung der Ständigen Impfkommission (STIKO) für die COVID-19-Impfempfehlung
2020 · Vygen-Bonnet, Sabine, Koch, Judith, et al. · Publication server of the Robert Koch Institute (Robert Kock Institute) · 34
PDF
WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20–22 April 2021
2022 · Margaret A. Liu, Tiequn Zhou, et al. · Emerging Microbes & Infections · 33
PDF
Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency
2016 · K.S. Vannice, B.K. Giersing, et al. · Vaccine · 29
Accelerated Development of COVID-19 Vaccines: Technology Platforms, Benefits, and Associated Risks
2021 · Ralf Wagner, Eberhard Hildt, et al. · Vaccines · 24
PDF
Toxicity and antiviral activity of LY253963 against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats
1990 · Philip R. Wyde, Mark W. Ambrose, et al. · Antiviral Research · 24
Beschluss der STIKO zur 5. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung
2021 · Vygen-Bonnet, Sabine, Koch, Judith, et al. · Publication server of the Robert Koch Institute (Robert Kock Institute) · 21
PDF
Sicherheit und Verträglichkeit von monovalenten Masern- und kombinierten Masern-, Mumps-, Röteln- und Varizellenimpfstoffen
2013 · D. Mentzer, H. Meyer, et al. · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · 7
WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019
2020 · Rebecca Sheets, Hye-Na Kang, et al. · npj Vaccines · 6
PDF
Mutual recognition in the European system: A blueprint for increasing access to medicines?
2019 · Ivana Škrnjug, Sabina Uzeirbegović, et al. · Regulatory Toxicology and Pharmacology · 6
PDF
Leveraging WHO’s Global Benchmarking Tool to strengthen capacity in clinical trials oversight for public health emergencies: the GHPP VaccTrain model
2022 · Solomon Owusu Sekyere, Ivana Škrnjug-Yudov, et al. · Globalization and Health · 4
PDF
The Pivotal Role of Quality Technical Structures for Clinical Trials Oversight in the Achievement of Long-Term Capacity Strengthening Outcomes
2022 · Solomon Owusu Sekyere, Ivana Škrnjug-Yudov, et al. · Frontiers in Medicine · 3
WHO informal consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 27–28 April 2017
2017 · Meenu Wadhwa, Hye-Na Kang, et al. · Biologicals · 3
Prüfung von Impfstoffen
2014 · A. Merkle, H. Lechner, et al. · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · 1
Potency estimation of vaccine batches remains unaffected by anesthesia for intracerebral injection
2012 · Elisabeth Kamphuis, Kay-Martin Hanschmann, et al. · Biologicals
Works count: 22
Citation count: 375
H-index: 10
I10-index: 10
Year
Topic
Type